Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (84740)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 31, 2019 (publication date) through Jul 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Meta-Analysis
ISSN
2308-3840
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Papazafiropoulou A, Melidonis A. Antidiabetic agents in patients with hepatic impairment. World J Meta-Anal 2019; 7(8): 380-388 [DOI: 10.13105/wjma.v7.i8.380] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i8/380.htm |
| Number | Citing Articles |
| 1 |
Pankaj Puri, Narendra Kotwal. An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist. Journal of Clinical and Experimental Hepatology 2022; 12(2): 560 doi: 10.1016/j.jceh.2021.09.010
|
| 2 |
André J. Scheen. Pharmacokinetic, toxicological, and clinical considerations for the treatment of type 2 diabetes in patients with liver disease: a comprehensive update. Expert Opinion on Drug Metabolism & Toxicology 2023; 19(8): 543 doi: 10.1080/17425255.2023.2252333
|
| 3 |
Zeinab Seif El-Din, Mohammed Afify, Essam Zayed, Dalia Elsabaawy, El Sayed Tharwa, Ahmed Elsharawy, Eman Abdelsameea, Mohamed Akl Rady. Dapagliflozin as an oral antihyperglycemic agent in the management of diabetes mellitus in patients with liver cirrhosis. World Journal of Experimental Medicine 2024; 14(4): 95272 doi: 10.5493/wjem.v14.i4.95272
|
| 4 |
Yasuo Terauchi, Makiko Usami, Tomoyuki Inoue. The Durable Safety and Effectiveness of Lixisenatide in Japanese People with Type 2 Diabetes: The Post-Marketing Surveillance PRANDIAL Study. Advances in Therapy 2022; 39(6): 2873 doi: 10.1007/s12325-022-02121-5
|
| 5 |
M. Ganeva. SAFETY PROFILE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS. Trakia Journal of Sciences 2023; 21(1): 54 doi: 10.15547/tjs.2023.01.009
|
| 6 |
Reem Al Argan, Dania Alkhafaji, Abdulmohsen Al Elq, Waleed Albaker, Yasir Elamin, Abrar Alwaheed, Mohammad Zeeshan, Zainab AlElq, Malak Alkhalifa, Rana Al Mansour, Shada Alghamdi, Abdulelah Al Ghamdi, Fatema Ismaeel, Adnan Almarzouq, Fatma Zainuddin, Reem AlSulaiman. The association between serum ferritin and bilirubin with glycemic control among patients with type 2 diabetes mellitus. Journal of Medicine and Life 2023; 16(11): 1670 doi: 10.25122/jml-2023-0136
|
| 7 |
Manpreet S. Mundi, Saketh Velapati, Janki Patel, Todd A. Kellogg, Barham K. Abu Dayyeh, Ryan T. Hurt. Evolution of NAFLD and Its Management. Nutrition in Clinical Practice 2020; 35(1): 72 doi: 10.1002/ncp.10449
|